Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Baltimore · cancer center | United States | 0 | 3,313 | 48,889 | #10 | ||
Lausanne · hospital | Switzerland | none recorded | 0 | 814 | 27,985 | - | |
Brussels · cancer center | Belgium | none recorded | 0 | 469 | 8,888 | - | |
Madison, WI · cancer center | United States | 0 | 396 | 7,567 | - | ||
Indianapolis, IN · cancer center | United States | 0 | 323 | 5,574 | - | ||
Birmingham · hospital | United Kingdom | none recorded | 0 | 239 | 2,123 | - | |
Varanasi · cancer center | India | none recorded | 0 | 77 | 259 | - | |
Kampala · cancer center | Uganda | none recorded | 0 | 71 | 274 | - | |
Butaro · cancer center | Rwanda | none recorded | 0 | 6 | 3 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Low-risk gestational trophoblastic neoplasia but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.